Cynthia J. Moreland - 20 Oct 2021 Form 4 Insider Report for Transphorm, Inc.

Role: Director
Signature: /s/ Cameron McAulay, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 20 Oct 2021
Net transactions value: $0
Form type: 4
Filing time: 22 Oct 2021, 16:04:09 UTC
Next filing: 13 Oct 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TGAN	Common Stock	Award	$0	+30,000		$0.000000	30,000	20 Oct 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TGAN	Stock Option (right to buy)	Award	$0	+50,000		$0.000000	50,000	20 Oct 2021	Common Stock	50,000	$4.40	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share is represented by a Restricted Stock Unit ("RSU"). One-fourth (1/4) of the RSUs will vest on October 20, 2022, and the remaining shares will vest in equal quarterly installments over the following three years, subject to the Reporting Person's continued service as of each such vesting date.
F2	One-fourth (1/4) of the shares subject to the option will vest on October 20, 2022, and the remaining shares will vest in equal quarterly installments over the following three years, subject to the Reporting Person's continued service as of each such vesting date.